# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1775690 | F | Cytotoxicity against mutant K-ras-transformed human T29Kt1 cells assessed as cell viability after 3 days by sulforhodamine B assay | Homo sapiens | 70 | cell-based format | Scientific Literature | ||
2. | ALA1775691 | A | Cytotoxicity against human T29 cells assessed as cell viability after 3 days by sulforhodamine B assay | Homo sapiens | 70 | cell-based format | Scientific Literature | ||
3. | ALA1775692 | F | Cytotoxicity against human H460 cells assessed as cell viability after 3 days by sulforhodamine B assay | Homo sapiens | 70 | cell-based format | Scientific Literature | ||
4. | ALA1775693 | P | Stability of compound at pH 4 | 26 | small-molecule physicochemical format | Scientific Literature | |||
5. | ALA1775694 | P | Stability of compound at pH 6 | 26 | small-molecule physicochemical format | Scientific Literature | |||
6. | ALA1775695 | P | Stability of compound at pH 7.4 | 49 | small-molecule physicochemical format | Scientific Literature | |||
7. | ALA1775696 | P | Stability of compound at pH 9 | 26 | small-molecule physicochemical format | Scientific Literature | |||
8. | ALA1775697 | P | Stability of compound at pH 2 | 49 | small-molecule physicochemical format | Scientific Literature | |||
9. | ALA1775699 | F | Antitumor activity against human NCI-H157 cells assessed as cell viability after 3 days by sulforhodamine B assay | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
10. | ALA1775700 | F | Antitumor activity against human H460 cells assessed as cell viability after 3 days by sulforhodamine B assay | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
11. | ALA1775701 | F | Antitumor activity against human H1299 cells assessed as cell viability after 3 days by sulforhodamine B assay | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
12. | ALA1775702 | F | Antitumor activity against human NCI-H322 cells assessed as cell viability after 3 days by sulforhodamine B assay | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
13. | ALA1775703 | B | Inhibition of RNA pol2 CTD phosphorylation in human NCI-H157 cells at 1 uM after 12 hrs by Western blot analysis | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
14. | ALA1775704 | B | Inhibition of RNA pol2 CTD phosphorylation in human H460 cells at 1 uM after 12 hrs by Western blot analysis | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
15. | ALA1775705 | B | Inhibition of RNA pol2 CTD phosphorylation in human H1299 cells at 1 uM after 12 hrs by Western blot analysis | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
16. | ALA1775787 | B | Inhibition of RNA pol2 CTD phosphorylation in human NCI-H322 cells at 1 uM after 12 hrs by Western blot analysis | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
17. | ALA3388505 | F | Anticancer activity against human NCI-H157 cells at 0.03 to 30 uM by sulforhodamine B assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
18. | ALA3388506 | F | Anticancer activity against human H460 cells at 0.03 to 30 uM by sulforhodamine B assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
19. | ALA3388507 | F | Anticancer activity against human Calu3 cells at 0.03 to 30 uM by sulforhodamine B assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
20. | ALA3388508 | F | Anticancer activity against human H1299 cells at 0.03 to 30 uM by sulforhodamine B assay | Homo sapiens | 2 | cell-based format | Scientific Literature |